A UHPLC–MS/MS method for the simultaneous determination of vancomycin, norvancomycin, meropenem, and moxalactam in human plasma and its clinical application

We developed an ultra‐high‐performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) method to determine four antibacterial drugs in human plasma for clinical usage. Samples were prepared using protein precipitation with methanol. Chromatographic separation was accomplished in 4.5 min...

Full description

Saved in:
Bibliographic Details
Published in:Journal of mass spectrometry. 2023-06, Vol.58 (6), p.e4925-n/a
Main Authors: Huo, Jiping, Guo, Yangyang, Zhang, Bo, Zhao, Zhigang, Shi, Guangzhi, Mei, Shenghui
Format: Article
Language:English
Subjects:
Acetates
Acetic acid
Ammonium
Ammonium acetate
Ammonium compounds
Antibiotics
Blood plasma
Central nervous system
Chromatography
Chromatography, High Pressure Liquid - methods
Concentration gradient
Flow rates
Humans
Ionization
Ions
Isomers
Liquid chromatography
Mass spectrometry
Mass spectroscopy
Meropenem
Methanol
Methods
Moxalactam
norvancomycin
Pharmacokinetics
Storage conditions
Tandem Mass Spectrometry - methods
UHPLC–MS/MS
Vancomycin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We developed an ultra‐high‐performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) method to determine four antibacterial drugs in human plasma for clinical usage. Samples were prepared using protein precipitation with methanol. Chromatographic separation was accomplished in 4.5 min on a BEH C18 column (2.1 × 50 mm, 1.7 μm) using a gradient elution of methanol and water (containing 7.71 g/L concentrated ammonium acetate, adjusted to pH 6.5 with acetic acid) at a flow rate of 0.4 mL/min. Positive electrospray was used for ionization. The method was linear in the concentration range 1–100 μg/mL for vancomycin, norvoncomycin, and meropenem; and 0.5–50 μg/mL for R‐isomer of moxalactam and S‐isomer of moxalactam. For all analytes, the intra‐ and inter‐day accuracies and precisions were −8.47%–10.13% and less than 12%, respectively. The internal standard normalized recoveries and matrix effect were 62.72%–105.78% and 96.67%–114.20%, respectively. All analytes were stable at six storage conditions, with variations of less than 15.0%. The method was applied in three patients with central nervous system infection. The validated method might be useful for routine therapeutic drug monitoring and pharmacokinetic study.
ISSN:1076-5174
1096-9888
DOI:10.1002/jms.4925